Targeting Leukotrienes in Kidney Disease
NCT05362474
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
6
Enrollment
OTHER
Sponsor class
Stopped
Funding not available
Conditions
Diabetic Kidney Disease
Interventions
DRUG:
Montelukast
Sponsor
University of Colorado, Denver